跳至主要内容
临床试验/IRCT20100209003320N24
IRCT20100209003320N24招募中3 期

The effect of vitamin D3 supplementation (cholecalciferol) on nutritional status, VDR gene expression, endocrine, metabolic, and adipokine parameters in patients with benign breast tumors:Randomized controlled clinical trial

Tabriz University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 years 至 50 years(—)
性别
Female

入选标准

  • Histopathological evidence of BBT (fibrocystic, fibroadenoma, etc.)
  • Age between 19 and 50 years
  • At least two years since diagnosis
  • willingness to cooperate and complete the informed consent form
  • Serum vitamin D deficiency (less than 20 ng/ml)

排除标准

  • Malabsorption disorders (such as Crohn's disease, celiac disease), biliary tract obstruction
  • Acute or chronic conditions (including various types of cancer, liver, kidney, and acute heart failure), hyperthyroidism, hormonal disorders prior to diagnosis (e.g., polycystic ovary syndrome (PCOS)), type 1 diabetes, hypoglycemia, adrenal gland disorders
  • Grade 3 obesity
  • A daily calorie intake of less than 800 or more than 3500 kcal/d
  • Any benign lesions in other organs
  • Chemotherapy
  • Radiotherapy
  • Hormone therapy
  • Cystectomy surgery
  • Use of glucocorticoid, anti-seizure, contraceptive, and HRT medications
  • Consuming more than 2000 mg of cod liver oil
  • Taking painkillers containing caffeine

研究者

相似试验